RxDoctor Payments Data

Abhishek Aphale, MD

MOHS-Micrographic Surgery · Philadelphia, PANPI 1437300993

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 28.1% of the total. That places this record below the midpoint for mohs-micrographic surgery clinicians in PA, where the typical reported total is $1,161.

$295in general payments, 2019–2025

Across 16 payments — averaging $18.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$83
  • Lifenet Health$66
  • Integra Lifesciences Corporation$44
  • Genentech USA, Inc.$43
  • Lilly USA, LLC$23
  • Adaptive Biotechnologies Corporation$20
  • plus $16 from 1 others

What the payments were for

  • Food & beverage$295100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$295 in reported general payments places this provider in the 20th percentile of 48 mohs-micrographic surgery providers in Pennsylvania.

See all mohs-micrographic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$125,185
Medicare patients
247
Services billed
798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Betamethasone Dipropionate11$794
Metronidazole12$359
Triamcinolone Acetonide24$333
Cephalexin28$151
Ketoconazole11$137
Doxycycline Monohydrate17$113
Tramadol Hcl15$49
Amoxicillin17$21

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →